Myocardial fibrosis in hypertensive heart failure does quality rather than quantity matter?

Journal of the American College of Cardiology

Volumn 67, Issue 3, 2016, Pages 261-263

  Moon, James C ^a,b   Treibel, Thomas A ^a,b   Schelbert, Erik B ^c  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

biomarkers; cardiac interstitium; collagen; hypertension; matrix metalloproteinase 1

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN; COLLAGEN TYPE 1; INTERSTITIAL COLLAGENASE;

COLLAGEN DEGRADATION; CORRELATION ANALYSIS; CROSS LINKING; DIASTOLE; ENZYME DEGRADATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART MUSCLE COMPLIANCE; HEART MUSCLE FIBROSIS; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPERTENSIVE HEART FAILURE; LETTER; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; BLOOD; CARDIAC MUSCLE; FEMALE; MALE; METABOLISM; PATHOLOGY;

COLLAGEN TYPE I; FEMALE; HEART FAILURE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MYOCARDIUM;

EID: 84957800172     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.10.070     Document Type: Editorial

References (17)

1. Seneca LA. Letter XLV: On Sophistical Argumentation. In: Gummere RM, translator. Moral Epistles, Vol. I. The Loeb Classical Library. Cambridge, MA: Harvard University Press, 1917-25:291.
2. E. Braunwald Heart failure. J Am Coll Cardiol HF 1 2013 1 20
3. M. Vaduganathan, S.J. Greene, A.P. Ambrosy, and et al. The disconnect between phase II and phase III trials of drugs for heart failure Nat Rev Cardiol 10 2013 85 97
4. J.J.V. McMurray, Stamatis Adamopoulos, S.D. Anker, et al. for the ESC Committee for Practice Guidelines ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
5. K.T. Weber Cardiac interstitium in health and disease: the fibrillar collagen network J Am Coll Cardiol 13 1989 1637 1652
6. C.F. Azevedo, M. Nigri, M.L. Higuchi, and et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease J Am Coll Cardiol 56 2010 278 287
7. L.T. Cooper, K.L. Baughman, A.M. Feldman, and et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology J Am Coll Cardiol 50 2007 1914 1931
8. R.S. Vasan Biomarkers of cardiovascular disease: molecular basis and practical considerations Circulation 113 2006 2335 2362
9. D.A. Morrow, and J.A. de Lemos Benchmarks for the assessment of novel cardiovascular biomarkers Circulation 115 2007 949 952
10. B. López, S. Ravassa, A. González, and et al. Myocardial collagen cross-linking is associated with heart failure hospitalization in patients with hypertensive heart failure J Am Coll Cardiol 67 2016 251 260
11. Y.Y. Li, Y. Feng, C.F. McTiernan, and et al. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices Circulation 104 2001 1147 1152
12. B. López, A. González, D. Lindner, and et al. Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase? Cardiovasc Res 99 2013 111 120
13. M. Grigorescu Noninvasive biochemical markers of liver fibrosis J Gastrointestin Liver Dis 15 2006 149 159
14. D.R. Thickett, A.R. Poole, and A.B. Millar The balance between collagen synthesis and degradation in diffuse lung disease Sarcoidosis Vasc Diffuse Lung Dis 18 2001 27 33
15. L.F. Morton, and M.J. Barnes Collagen polymorphism in the normal and diseased blood vessel wall. Investigation of collagens types I, III and V Atherosclerosis 42 1982 41 51
16. S.R. Langley, J. Dwyer, I. Drozdov, and et al. Proteomics: from single molecules to biological pathways Cardiovasc Res 97 2013 612 622
17. T.C. Wong, K.M. Piehler, I.A. Kang, and et al. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission Eur Heart J 35 2014 657 664